A causal learning framework for the analysis and interpretation of COVID-19 clinical data.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 12 06 2021
accepted: 27 04 2022
entrez: 19 5 2022
pubmed: 20 5 2022
medline: 24 5 2022
Statut: epublish

Résumé

We present a workflow for clinical data analysis that relies on Bayesian Structure Learning (BSL), an unsupervised learning approach, robust to noise and biases, that allows to incorporate prior medical knowledge into the learning process and that provides explainable results in the form of a graph showing the causal connections among the analyzed features. The workflow consists in a multi-step approach that goes from identifying the main causes of patient's outcome through BSL, to the realization of a tool suitable for clinical practice, based on a Binary Decision Tree (BDT), to recognize patients at high-risk with information available already at hospital admission time. We evaluate our approach on a feature-rich dataset of Coronavirus disease (COVID-19), showing that the proposed framework provides a schematic overview of the multi-factorial processes that jointly contribute to the outcome. We compare our findings with current literature on COVID-19, showing that this approach allows to re-discover established cause-effect relationships about the disease. Further, our approach yields to a highly interpretable tool correctly predicting the outcome of 85% of subjects based exclusively on 3 features: age, a previous history of chronic obstructive pulmonary disease and the PaO2/FiO2 ratio at the time of arrival to the hospital. The inclusion of additional information from 4 routine blood tests (Creatinine, Glucose, pO2 and Sodium) increases predictive accuracy to 94.5%.

Identifiants

pubmed: 35588440
doi: 10.1371/journal.pone.0268327
pii: PONE-D-21-19339
pmc: PMC9119448
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0268327

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Diabetes Care. 2020 Oct;43(10):2345-2348
pubmed: 32788285
Respir Med. 2020 Sep;171:106096
pubmed: 32763754
PLoS One. 2020 Aug 5;15(8):e0237126
pubmed: 32756608
J Bioinform Comput Biol. 2003 Jul;1(2):231-52
pubmed: 15290771
N Engl J Med. 2000 May 4;342(18):1334-49
pubmed: 10793167
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1684-1707
pubmed: 33629339
Biometrika. 1948 May;35(Pts 1-2):145-56
pubmed: 18867419
Aging Clin Exp Res. 2020 Sep;32(9):1869-1878
pubmed: 32734576
Nat Commun. 2020 Dec 9;11(1):6317
pubmed: 33298944
Lancet Digit Health. 2020 Oct;2(10):e516-e525
pubmed: 32984797
Eur J Integr Med. 2021 Apr;43:101313
pubmed: 33619437
J Am Coll Cardiol. 2020 Jul 7;76(1):85-92
pubmed: 32407772
Multimed Syst. 2021 Mar 28;:1-15
pubmed: 33814730
Crit Care. 2020 Jul 2;24(1):389
pubmed: 32616077
Res Sq. 2021 Mar 01;:
pubmed: 33688642
J Infect. 2020 Aug;81(2):e16-e25
pubmed: 32335169
BMC Bioinformatics. 2011 Mar 31;12:89
pubmed: 21453508
Geriatr Gerontol Int. 2021 Feb;21(2):172-177
pubmed: 33340212
Kidney Int. 2020 May;97(5):829-838
pubmed: 32247631
PLoS One. 2020 Dec 29;15(12):e0244177
pubmed: 33373384
BMJ. 2020 Apr 7;369:m1328
pubmed: 32265220
J Med Internet Res. 2020 Dec 15;22(12):e20756
pubmed: 33284779
Nat Rev Urol. 2020 Jul;17(7):365-367
pubmed: 32377015
J Pathol Inform. 2016 Dec 30;7:50
pubmed: 28163973
J Biomed Inform. 2014 Apr;48:94-105
pubmed: 24361389
Nat Commun. 2020 Aug 11;11(1):3923
pubmed: 32782264
PLoS One. 2021 Feb 16;16(2):e0246190
pubmed: 33592019
Artif Intell Med. 2011 Nov;53(3):181-204
pubmed: 21958683
Breathe (Sheff). 2015 Sep;11(3):194-201
pubmed: 26632351
Ann Hepatol. 2021 Mar-Apr;21:100273
pubmed: 33075578
J Stroke Cerebrovasc Dis. 2020 Nov;29(11):105283
pubmed: 33066922

Auteurs

Elisa Ferrari (E)

Scuola Normale Superiore, Pisa, Italy.

Luna Gargani (L)

Institute of Clinical Physiology, C.N.R, Pisa, Italy.

Greta Barbieri (G)

Department of Surgical, Medical, Molecular and Critical Area Pathology, University of Pisa, Pisa, Italy.
Emergency Medicine Department, Pisa University Hospital, Pisa, Italy.

Lorenzo Ghiadoni (L)

Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Francesco Faita (F)

Institute of Clinical Physiology, C.N.R, Pisa, Italy.

Davide Bacciu (D)

Department of Computer Science, University of Pisa, Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH